Key Metrics 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
SRHHL Industries Ltd. (Amalgamated) (SRHHLINDST)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524410 NSE: SRHHLINDST Power Generation/Distribution | Small Cap | SRHHL Ind (Amalgamat Share Price
BSE Share Price
Not Listed
Not Listed
SRHHL Industries Ltd. (Amalgamated) (SRHHLINDST)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524410 NSE: SRHHLINDST Power Generation/Distribution | Small Cap | SRHHL Ind (Amalgamat Share Price
BSE Share Price
Not Listed
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹6 Cr.
Current Price
₹0
52-Week Low / High
₹4 / 5
TTM EPS
₹0.1
TTM Sales
₹0.9 Cr.
Book Value per Share
₹22.7
P/E Ratio
39.63
Industry PE
29.3
Price to Book (P/B)
0.22
Price to Sales (P/S)
6.66
EV/EBITDA
9.64
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
1.05%
Return on Capital Employed (ROCE)
1.25%
Return on Assets (ROA)
1.01%
Operating Profit Margin
-1,311.9%
Net Profit Margin
1660.06%
Gross Profit Margin
3,796.7%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-84.62%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
Improving versus 3-year growth rate
172.73%
Asset Quality
Promoter Holding
26.49%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹16 Cr.
Equity
₹12.5 Cr.
Face Value
₹10
All Time Low / High
₹0.60 / 27.50
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation ⓘ
| Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 4% | 4.6% | 0% | 3.6% | 1.1% | 1.3% | 0.9% | -3.9% | 0.7% | 1.3% | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 44.6 | 58.2 | 0 | 59.2 | 0.5 | 0.3 | 0.3 | 0.2 | 0.1 | 0 | 1 |
| Sales YoY Gr. | - | 30.7% | -100% | NA | -99.1% | -42.6% | -12.9% | -18.5% | -40.9% | -84.6% | - |
| Adj EPS ⓘ | 0.6 | 0.7 | 0 | 0.2 | -0.1 | 0 | -0.1 | -0.4 | 0.1 | 0.2 | 0.1 |
| YoY Gr. | - | 13.3% | -100% | NA | -166.7% | NA | -750% | NA | NA | 118.2% | - |
| BVPS (₹) ⓘ | 21.9 | 20.6 | 0 | 20.9 | 23.4 | 23.3 | 23.5 | 22.3 | 22.3 | 22.6 | 22.7 |
| Adj Net Profit ⓘ | 1.9 | 2.1 | 0 | 0.6 | -0.2 | 0 | -0.2 | -0.5 | 0.1 | 0.3 | 0 |
| Cash Flow from Ops. ⓘ | 5.6 | 1.8 | 0 | 10 | -29.3 | 4.1 | 2 | -0.5 | 0.2 | 0.5 | - |
| Debt/CF from Ops. ⓘ | 3.3 | 15.6 | 0 | 3 | -0.3 | 0.8 | 0.4 | 0 | 0 | 0 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | -57.5% | -48.3% | -58% | -84.6% | ||||
| Adj EPS ⓘ | -9.7% | NA | NA | 118.2% | ||||
| BVPSⓘ | 0.4% | -0.7% | -1.3% | 1.1% | ||||
| Share Price | - | - | - | - | ||||
Key Financial Parameters ⓘ
| Mar'02 | Mar'03 | Mar'04 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 2.6 | 3.2 | 0 | 0.9 | -0.3 | 0.1 | -0.6 | -1.8 | 0.5 | 1.1 | 0.6 |
| Op. Profit Mgn % ⓘ | 10.4 | 8.6 | 0 | 6.7 | 29.8 | 45.3 | -159.7 | 15.2 | -104.5 | -1311.9 | 55.4 |
| Net Profit Mgn % ⓘ | 4.2 | 3.6 | 0 | 1 | -26.9 | 9.9 | -60.7 | -238.7 | 113.6 | 1660.1 | 17.5 |
| Debt to Equity ⓘ | 0.3 | 0.4 | 0 | 0.4 | 0.3 | 0.1 | 0 | 0 | 0 | 0 | - |
| Working Cap Days ⓘ | 257 | 181 | 0 | 165 | 12,447 | 7,648 | 5,616 | 5,142 | 9,366 | 70,137 | 498 |
| Cash Conv. Cycle ⓘ | 63 | 48 | 0 | 51 | 4,268 | 1,595 | 1,374 | -3 | -12 | -19 | 378 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'01 | Mar'02 | Mar'03 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 44.10 | 44.55 | 58.23 | 59.24 | 0.54 | 0.31 | 0.27 | 0.22 | 0.13 | 0.02 |
| Operating Expenses ⓘ + | 40.13 | 39.94 | 53.39 | 55.29 | 0.38 | 0.17 | 0.71 | 0.19 | 0.26 | 0.25 |
| Operating Profit ⓘ | 3.98 | 4.61 | 4.85 | 3.95 | 0.16 | 0.14 | -0.44 | 0.03 | -0.13 | -0.23 |
| Operating Profit Margin (%) | 9.0% | 10.3% | 8.3% | 6.7% | 29.8% | 45.3% | -159.0% | 15.2% | -104.0% | -1,311.9% |
| Other Income ⓘ + | 1.94 | 1.51 | 1.88 | 3.07 | 1.27 | 0.43 | 1.22 | 0.61 | 0.67 | 0.91 |
| Interest ⓘ | 1.37 | 1.45 | 1.90 | 2.57 | 0.65 | 0.27 | 0 | 0 | 0 | 0 |
| Depreciation ⓘ | 2.54 | 2.54 | 2.66 | 3.61 | 0.69 | 0.12 | 0.50 | 0.33 | 0.32 | 0.33 |
| Profit Before Tax ⓘ | 2 | 2.14 | 2.17 | 0.84 | 0.09 | 0.17 | 0.28 | -1.12 | 0.18 | 0.35 |
| Tax ⓘ | 0.17 | 0.28 | 0.18 | 0.19 | 0.01 | 0 | 0.03 | 0.40 | 0.07 | 0.05 |
| Profit After Tax | 1.83 | 1.86 | 1.99 | 0.64 | 0.08 | 0.17 | 0.25 | -1.52 | 0.11 | 0.30 |
| PAT Margin (%) | 4.2% | 4.2% | 3.4% | 1.1% | 14.9% | 56.3% | 91.2% | -694.0% | 90.2% | 1,660.1% |
| Adjusted EPS (₹) | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.2 | -1.2 | 0.1 | 0.2 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Valuation of SRHHL Ind (Amalgamat - Standalone
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'01 | Mar'02 | Mar'03 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 66.78 | 68.73 | 64.66 | 68.72 | 29.23 | 29.06 | 29.31 | 27.80 | 27.88 | 28.18 | |
| Debt + | 19.82 | 18.35 | 27.36 | 29.57 | 7.40 | 3.44 | 0.69 | 0 | 0 | 0 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 4.67 | 4.04 | 4.59 | 4.34 | 0.01 | 0.01 | 0.01 | 0 | 0.03 | 0.02 | |
| Others Liabilities ⓘ | 14.80 | 16.49 | 13.37 | 16.98 | 1.03 | 3.13 | 1.97 | 1.22 | 1.17 | 1.22 | |
| Total Liabilities ⓘ | 106.07 | 107.62 | 109.98 | 119.62 | 37.66 | 35.64 | 31.98 | 29.02 | 29.08 | 29.42 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 42.80 | 44.17 | 42.41 | 55.28 | 14.57 | 11.37 | 10.87 | 7.38 | 7.38 | 7.05 | |
| CWIP ⓘ | 6.43 | 6.22 | 13.71 | 2.50 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Investments ⓘ | 20.80 | 21.06 | 23.35 | 31.61 | 15.52 | 18.91 | 18.03 | 17.93 | 17.93 | 17.93 | |
| Inventories | 4.42 | 5.53 | 4.98 | 4.58 | 0.16 | 0.16 | 0 | 0 | 0 | 0 | |
| Trade Receivables | 9.94 | 7.79 | 9.57 | 9.75 | 0.49 | 1.90 | 0 | 0 | 0 | 0 | |
| Cash Equivalents | 0.58 | 0.76 | 0.87 | 0.71 | 0 | 0.01 | 0.03 | 0.58 | 0.46 | 0.93 | |
| Others Assets ⓘ | 21.10 | 22.09 | 15.08 | 15.19 | 6.92 | 3.29 | 3.05 | 3.13 | 3.32 | 3.51 | |
| Total Assets ⓘ | 106.07 | 107.62 | 109.98 | 119.62 | 37.66 | 35.64 | 31.98 | 29.02 | 29.08 | 29.42 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'01 | Mar'02 | Mar'03 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 18.35 | 5.60 | 1.76 | 9.96 | -29.26 | 4.09 | 1.96 | -0.49 | 0.20 | 0.50 |
| Cash Flow From Investing Activity ⓘ + | -14.80 | -3.95 | -10.70 | -9.86 | 58.52 | -0.31 | 0.88 | 1.75 | -0.31 | 0 |
| Cash Flow From Financing Activity ⓘ + | -3.66 | -1.47 | 9.05 | -0.30 | -29.97 | -3.78 | -2.82 | -0.71 | -0.02 | -0.02 |
| Net Cash Flow ⓘ | -0.11 | 0.18 | 0.11 | -0.21 | -0.71 | 0 | 0.03 | 0.55 | -0.12 | 0.47 |
Financial Ratio
| PARTICULARS | Mar'01 | Mar'02 | Mar'03 | Mar'05 | Mar'06 | Mar'07 | Mar'08 | Mar'09 | Mar'10 | Mar'11 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 3.34 | 2.77 | 2.99 | 0.96 | 0.17 | 0.6 | 0.85 | -5.34 | 0.41 | 1.05 |
| ROCE (%) | 3.92 | 3.98 | 4.56 | 3.58 | 1.1 | 1.29 | 0.9 | -3.86 | 0.65 | 1.25 |
| Asset Turnover Ratio | 0.52 | 0.46 | 0.6 | 0.57 | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
| PAT to CFO Conversion(x) | 10.03 | 3.01 | 0.88 | 15.56 | -365.75 | 24.06 | 7.84 | N/A | 1.82 | 1.67 |
| Working Capital Days | ||||||||||
| Receivable Days | 70.50 | 65.30 | 48.70 | 54 | 3,435.70 | 1,415.60 | 0 | 0 | 0 | 0 |
| Inventory Days | 33.20 | 36.60 | 29.40 | 26.70 | 1,591.20 | 189.30 | 0 | 0 | 0 | 0 |
| Payable Days | 0 | -1,357.60 | 1,780.70 | 3,882.50 | 0 | 0 | 0 | 0 | 0 | 0 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
SRHHL Industries Ltd. (Amalgamated) FAQs
The current trading price of SRHHL Ind (Amalgamat on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of SRHHL Ind (Amalgamat stood at ₹6.22 Cr
The latest P/E ratio of SRHHL Ind (Amalgamat as of 31-Dec-1969 is 39.63.
The latest P/B ratio of SRHHL Ind (Amalgamat as of 31-Dec-1969 is 0.22.
The 52-week high of SRHHL Ind (Amalgamat is ₹5.24 and the 52-week low is ₹4.45.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of SRHHL Ind (Amalgamat is ₹0.93 ( Cr.) .
Data is not available for this company.
No data found
No data found
About SRHHL Industries Ltd. (Amalgamated)
SRHHL Industries Limited, formerly known as Sree Rayalaseema Hi-Strength Hypo, is the torchbearer of the TGV Group. It is the only Indian manufacturer of Calcium Hypochlorite, and one of the very few in the world.
The Rs 750 crore TGV conglomerate is backed by a rich and varied experience spanning more than two glorious decades, is a rapidly growing, well-diversified one, with interests in Chemicals, Financial services, Merchant Banking, Securities, Real Estate, Power, Pharmaceuticals, Healthcare, Hospitality, Entertainment, Information Technology, Personal Products, Salt and Aquaculture. A constant effort to keep pace with change underlines all its endeavours. A 3000+ strong manpower base strengthens the conglomerate's resolve to excel.
A state-of-the-art sodium process technology developed through in-house R&D efforts helps the company in manufacturing the product with a chlorine content of 65% to 70%. Sree Rayalaseema Hi-Strength Hypo Ltd. exports Calcium Hypochlorite to countries all across the globe viz., Australia, Bangladesh, Belgium, Brunei, China, Colombia, Cyprus, Durban, England, France, Germany, Hungary, Iran, Kenya, Korea, Malaysia, Mauritius, Netherlands, Oman, Peru, Philippines, Qatar, Sri Lanka, Saudi Arabia, Singapore, Tanzania, Thailand, USA, Vietnam, etc.
The Certificate of Merit awarded by CHEMEXCIL for outstanding export performance reinforces its status as a recognized export house
Calcium Hypochlorite touches vital facets of human existence and is of proven importance in many areas of day-to-day activity. Sree Rayalaseema Hi-Strength Hypo Ltd. has a distinctive edge in the manufacture of this product, thanks to the twin advantages of indigenous raw materials availability and supply of some specialized chemicals by Sree Rayalaseema Alkalies and Allied Chemicals Ltd. The company is also a front-ranking producer of Monochloro Acetic Acid. Manufactured by the scientific crystallizer technology, the product meets international quality standards. Monochloro Acetic Acid is used by all leading manufacturers of Non-Steroid Anti-Inflammatory Drugs, other pharmaceuticals, pesticides, organic chemicals, etc.
Product range of the company includes:
- Calcium hypochlorite
- Stable bleaching powder
- Aluminium sulphate
- Monochloro acetic acid
- Sulphuric acid
- Chlorosulphonic acid
- Hydrochloric acid
- Oleum 23% & 65%
Achievements/ recognition:
Certification
- ISO 14001 certification for Environmental Management
- ISO 9001 : 9002 certification for Quality Systems
Awards
- National Awards for Unity, Safety, Scientific Industrial Research
- National Awards for Safety
- National Award Environmental Protection, Research & Development and Energy Conservation
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
